Eagle Bay Advisors LLC Roivant Sciences Ltd. Transaction History
Eagle Bay Advisors LLC
- $157 Million
- Q4 2024
A detailed history of Eagle Bay Advisors LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 506 shares of ROIV stock, worth $5,459. This represents 0.0% of its overall portfolio holdings.
Number of Shares
506
Previous 506
-0.0%
Holding current value
$5,459
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ROIV
# of Institutions
330Shares Held
507MCall Options Held
1.14MPut Options Held
2.32M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$711 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$710 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$584 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$476 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$382 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.6B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...